Pediatric Psychiatry Ethics in a Nutshell

A five-year government supported study, “Affective Neuroscience of Pediatric Bipolar Disorder,” was halted after  parents complained to the University of Illinois in Chicago. According to documents obtained by ProPublica Illinois, Dr. Mani Pavuluri, a prominent psychiatrist who had founded the Pediatric Mood . . . Continue reading →

FDA Forced Wyeth to REMOVE Suicide Warning from Effexor Label

FDA Forced Wyeth to REMOVE Suicide Warning from Effexor Label Wed, 8 Sep 2004 The Wall Street Journal reports that FDA officials forced Wyeth to remove the label warning stating: “In pediatric clinical trials, there were increased reports of hostility and, especially . . . Continue reading →

Lilly duloxetine drug trial–19 Quit after a suicide – Philadelphia Inquirer

Lilly duloxetine drug trial–19 Quit after a suicide – Philadelphia Inquirer Fri, 13 Feb 2004 19-year old Teri Johnson’s suicide occurred one week after an FDA advisory committee had urged the FDA to issue warnings about prescribing antidepressant drugs for children under . . . Continue reading →

Congress & the White House must remedy a prescription for danger – LA Times / CBS News

Congress & the White House must remedy a prescription for danger – LA Times / CBS News Thu, 1 Apr 2004 For those who missed the CBS evening News broadcast (Tues March 30) about FDA’s suppression of evidence, a video of that . . . Continue reading →

Concealed Drug Trial Results Mislead Doctors & Put Children’s Lives at Risk – NYT

Concealed Drug Trial Results Mislead Doctors & Put Children’s Lives at Risk – NYT Thu, 22 Jul 2004 The inordinate influence that drug companies wield on government healthcare regulatory policies–through campaign contributions to elected officials and lucrative job offers to public officials–has . . . Continue reading →

Fast growing business: Unethical clinical trials in India – Asia Times

Fast growing business: Unethical clinical trials in India – Asia Times Tue, 27 Jul 2004 Asia Times reports: “India increasingly emerges as a preferred destination for outsourcing clinical trials – testing of new drugs on humans – the country may also be . . . Continue reading →